We invest in disruptive companies with potential to dominate global markets. We look for companies and entrepreneurs with fundamentally strong business model. We take the time and effort to understand each idea and decide on its merits and potential through our comprehensive evaluation process.
Through our network and access to large corporations, we are able to further validate companies that can readily meet demand of large corporations and help them innovate in today’s digital world. We provide support to generating sales with large Fortune 500 clients. We help companies to scale and deliver through leveraging access to a network of engineers.
Our Advisory Board also provides mentoring support to the Management Team of the portfolio companies. We focus on three areas where we have significant domain and vertical expertise - Healthcare, Analytics and Cyber Security. This also brings in cross company leverage opportunities.
Through our network and access to large corporations, we are able to further validate companies that can readily meet demand of large corporations and help them innovate in today’s digital world. We provide support to generating sales with large Fortune 500 clients. We help companies to scale and deliver through leveraging access to a network of engineers.
Our Advisory Board also provides mentoring support to the Management Team of the portfolio companies. We focus on three areas where we have significant domain and vertical expertise - Healthcare, Analytics and Cyber Security. This also brings in cross company leverage opportunities.
Location: United States, California, Costa Mesa
Employees: 11-50
Founded date: 2015
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 18.07.2025 | GigaIO | gigaio.com | $40.2M | United Sta... |
Mentions in press and media 16
| Date | Title | Description |
| 24.07.2025 | GigaIO Secures $21M for AI Infrastructure Expansion | GigaIO secured $21 million in its first Series B funding tranche. Impact Venture Capital led the round. Funds will boost SuperNODE and Gryf production. These flagship products deliver scalable, energy-efficient AI inferencing infrastructure... |
| 18.07.2025 | GigaIO: $21 Million Closed For Scaling AI Inferencing Infrastructure Solutions | GigaIO, a leader in scalable AI inferencing infrastructure, has secured $21 million in the first tranche of its Series B financing, led by Impact Venture Capital with contributions from CerraCap Ventures, G Vision Capital, Mark IV Capital, ... |
| 17.07.2025 | GigaIO Raises $21M in First Tranche of Series B Funding | GigaIO, a Carlsbad, CA-based provider of scalable infrastructure designed for AI inferencing, raised $21M in the First Tranche of its Series B funding. The round was led by Impact Venture Capital, with participation from CerraCap Ventures, ... |
| 10.02.2023 | CerraCap Ventures invests in Predicta Med, an autoimmune disease detection and intervention recommendation company | Predicta Med is building the world's first decision support platform for early detection and intervention recommendation of immune-related diseases. COSTA MESA, Calif., Feb. 10, 2023 /PRNewswire/ -- SoCal headquartered Venture Capital fund,... |
| 01.02.2023 | Wink Expands Seed Round With Additional $3M in New Funding | Wink's Biometric Authentication Platform with Face and Voice Verification Investing in Wink is not just about putting money into a cutting-edge technology company, it's about investing in the future of secure and seamless identity and payme... |
| 20.05.2021 | CerraCap Cares Invests in Aquagenuity™-an AI-Driven Water Solution Named as 1 of 7 Technologies Protecting the World's Waterways | |
| 05.01.2021 | CerraCap Ventures Invests in Biopharma AI Company Totient Inc. | |
| 30.11.2020 | CerraCap Ventures and Exfinity Venture Partners join forces for New Growth | |
| 17.11.2020 | CerraCap Ventures launches its Foundation and Impact initiative CerraCap Cares, aimed at innovating philanthropy and investing in technology for good | |
| 30.10.2020 | CerraCap Ventures Invests in Life Science AI Company rMark Bio, Inc. |
Show more